Measures how test compounds partition into target condensates, enabling rational design of therapeutics with desired potency and safety.
Phase-separation assays reveal how test compounds enrich or deplete in biological condensates, guiding compound design and selection.
Sequential DESI-MS spot analysis enables label-free enzyme screening with rapid product detection, kinetic measurement, and inhibitor assessment.